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 Introduction 
Dyslipidemia refers to the abnormal amounts of 
the lipids (e.g., cholesterol and/or fat) in the blood. 
Dyslipidemia is a disorder of lipoprotein metabolism, 
including lipoprotein over production or deficiency. 
Dyslipidemia may be manifested by elevation of total 
cholesterol, low Density Lipoprotein cholesterol LDL 
and triglycerides concentration and decrease in high 
density lipoprotein cholesterol (HDL) concentration in 
the blood i.e. presence of  abnormal serum lipid 
concentration of one or more types (1).
T h e r e i s n o d i r e c t r e f e r e n c e o f 
Dyslipidemia in Ayurvedic classics. It can be 
included under santarpanjanya vyadhias 
“Medoroga”. In many research s tudies 
h y p e r l i p i d e m i a i s t e r m e d b y d i f f e r e n t 
nomenclature, e.g. Rasagata SnehaVriddhi 
(increase in lipids in plasma), Rasa Raktagata 
SnehaVriddhi (increase in the lipids in plasma and 
blood), Medovriddhi (generalized lipid increase), 
Medoroga or Medodosha (obesity), Aam Medo 
Dhatu (abnormally formed adipose tissue) (2).
Agni is responsible for all metabolic 
activities in the body.  Agnimandya leads to 
production of Ama (undigested food). Ama is the 
main cause of all metabolic disorders in Ayurveda. 
This accumulated Ama is capable of obstructing the 
metabolic pathways and causing diseases. 
Cholesterol is considered as one such product that 
originates due to metabolic impairment in the 
alimentary tract and fat tissue (Meda).
W h e n t h e r e i s d e r a n g e m e n t o f 
Medodhatwagni, then it will lead to excess 
accumulat ion of abnormal quanti t ies of 
poshakamedodathu in rasa . This excess 
accumulat ion of abnormal quanti t ies of 
poshakamedodathu in rasa dhatu resembles 
hyperlipidaemia of modern medicine. The 
c o n s e q u e n c e o f s u c h i n c r e a s e i n 
Poshakamedodhatu leads to disorders such as 
Dhamanipratichaya described by Acharya Charak 
in Kaphajananatmajavyadhi (3).
In India, there has been an alarming 
increase in the prevalence of CVD over the past 
two decades that accounts for 24% of all deaths 
among adults aged 25–69 years (4). Prevalence of 
hypercholesterolemia according  to Indian Council 
of Medical Research (ICMR) Integrated Disease 
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Surveillance varies from 10-15% in rural to 
25-30% in urban populations (5).Treatment of 
Dyslipidemia can reduce the risk of heart disease 
by approximately 30% over a 5-year period. (6).
Need of study
The prevalence of Dyslipidemia is high and 
increases continuously in many developing countries as 
a result of the westernization of diet, obesity, aging of 
population, reduced physical activity, and other adverse 
lifestyle changes (7).Dyslipidemia is one of the most 
important and modifiable risk factors for cardiovascular 
diseases, which is also a major cause of morbidity and 
l e a d s t o m o r t a l i t y w o r l d w i d e ( 8 , 9 , 1 0 ) . 
Nidanparivarjana is the main treatment principle of 
Ayurveda. So if we are well acquainted with etiological 
factors of Dyslipidemia we can avoid it and keep 
ourselves healthy. The lifestyle modifications are also a 
part of the treatment regimen for patients with 
Dyslipidemia, regardless of pharmacological 
intervention. Hence, this study was undertaken to 
evaluate the factors responsible in development of 
Dyslipidemia.
Aims and objectives
Aim
Study of etiological factors of Dyslipidemia.
Objectives    
To study the risk factors related to Ahar 
(Dietary regimen).
To study the risk factors related to Vihar 
(Behavioral regimen)
Materials and methods 
Place of Study - OPD and IPD of Kayachikitsa 
Department of MGACH & RC, Salod (H), Wardha
Ethical clearance – It was obtained from Institutional 
Ethics committee of Datta Meghe Institute of Medical 
sciences, Sawangi (IEC No. DMIMS (DU)/ IEC/
2017-18/6355).
• Study Design: Observational Study
• Study Type: Analytical case control study 
• Sample size: Total -100 (each group 50)
• Grouping: Two Groups each of 50
• Group A-Control Group     
• Group B- Case Group 
Inclusion criteria
• Age group of 20-70 years irrespective of sex.
• Patients not having any systemic illness
• Diagnosed & confirmed cases of Dyslipidemia 
according to National Cholesterol Education Program 
and Adult Treatment Panel III (NCEP:ATPIII, 2001) 
as follows- 
i) Total cholesterol ≥200 mg/dL and/or
ii) LDL from 130 to 189 mg/dL and/or
iii) Sr.Triglycerides between 150 to 499 mg/dL 
and/or 
iv) Sr. HDL < 40mg/dL. 
Exclusion criteria
• Patient having systemic illness like Tuberculosis, 
Carcinoma, Endocrine disorders 
• and Renal or Liver disorder. 
• Drug induced Dyslipidemia
• Bed ridden patients.
• Subjects those who are unable to answer the 
questionnaire.
Group A- Case definition- Cases between age group of 
20-70 years not on any medications were screened for 
Lipid profile after 12 hours fasting and if reports are 
within normal level then taken under control group.
Group B- Case definition- Known cases of dyslipidemia 
between age group of 20-70 years. 
Selection of subjects
Patients of dyslipidemia came to the Outpatient 
Department of Kayachikitsa of Mahatma Gandhi 
Ayurved College Hospital and Research Centre, Salod 
(H), Wardha, from October, 2007, to July, 2009 were 
selected randomly for study. The study group comprised 
50 Diagnosed & confirmed cases of Dyslipidemia 
according to National Cholesterol Education Program 
and Adult Treatment Panel III (NCEP:ATPIII, 2001) 
between 20-70 years of age and an equal number of 
healthy volunteers, taken as controls, who consented to 
undergo the required investigations. The patients of 
both the groups were selected matched for age and sex. 
 Detailed history was obtained from cases and controls 
with regard to family history, prior treatment history, 
physical activity, and other lifestyle factors including 
tobacco and alcohol exposure. Special case proforma 
was prepared and each subject was examined according 
to the case proforma. Data related to weight, height, 
body mass index (BMI) and blood pressure was 
recorded. BMI was calculated as weight (kg)/[height 
(mt)]2.Institutional Ethical Committee clearance was 
obtained prior to the commencement of the study.
Fasting serum lipid profile was estimated using 
Vitros 250, fully automated analyzer, after a period of 
12-14 hours  of fasting.
Investigations
• Lipid profile-
• Total Cholesterol
• Triglycerides
• High density lipoproteins
• Low density lipoproteins
• Very low density lipoproteins
• Blood Glucose Level.
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Observations and results 
Assessment will be done by comparing the 
factors related to Dyslipidemia in both the groups.
Statistical analysis was done by using 
descriptive and inferential statistics using chi square test 
and Student’s unpaired t test and software used in the 
analysis were SPSS 22.0 version and Graph Pad Prism 
7.0 version and p<0.05 is considered as level of 
significance.
In Group A, 14 (28%) patients belonged to age 
group above 60 years followed by 13(26%) belonged to 
41-50 years, 10(20%) belonged to 51-60 years of age, 
8(16%) belonged to 21-30 years and 5(10%) patients 
belonged to 31-40 years. In group B, 17 (34%) patients 
belonged to 51-60 years followed by 11(20%) belonged 
to 31-40 years, 10(20%) patients belonged to more than 
60 years of age, 8(16%) patients belonged to 41-50 
years whereas only 4 (8%) patients belonged to  21-30 
years. Comparison of both groups regarding age was 
not significant.
In Group A, 29 (58%) patients were female and 
remaining was male. In Group B 32 (64%) patients 
were female and remaining was male. Comparison of 
both groups was not significant.
Regarding occupation, in group A, 15 (30%) 
patients were housewives, 14 (28%) patients were doing 
service, 10(20%) patients were labourer, 8(16%) were 
farmer and 3(6%) patients were businessmen. In group 
B, 19 (38%) patients were doing service, 17(34%) 
patients were housewives, 7(14%) patients were 
labourer , 4(8%) patients were farmer and 3(6%) 
patients were businessmen. Comparison of both groups 
was not significant.
Regarding marital status, in both groups 
43(86%) patients were married and remaining were 
unmarried. Comparison of both groups was not 
significant.
According to socio-economic status, in Group 
A, 36(72%) patients and in Group B 35(70%) patients 
were from middle socio-economic status and remaining 
were from poor socio-economic status. No any patient 
from high socio-economic status was found in both 
groups. Comparison of both groups showed not 
significant.
Family history of Dyslipidemia was present in 
18 (36%) patients and absent in 32(64%) patients in 
Group A whereas family history of Dyslipidemia was 
present in 29 (58%) patients and absent in 21(42%) 
patients of Group B. Comparison of two groups was 
significant with (P=0.027) value.
In Group A, 14 (28%) pat ients had 
Kaphapittaja prakruti whereas in Group B, 14(28%) 
patients had vatapittaja prakruti and 16 patients had 
kaphavataja and kaphapittaja prakruti. Comparison of 
both groups was significant     with P=0.0001 value.
In Group A, sama Agni was observed in 
25(50%) patients whereas mandaagni observed in 
14(28%) patients. In Group B, sama Agni was present 
in 32(64%) patients whereas manda Agni was present in 
15(30%) patients. Comparison of both groups was not 
significant.
In Group A, 25(50%) patients had BMI (kg/m2) 
between 25-29.9 kg/m2 and 12(24%) patients had BMI 
more than 30 kg/m2. In Group B, 25(50%) patients had 
BMI more than 30 kg/m2 and  20 (40%) patients had 
BMI between 25-29.9 kg/m2. In  Group A, 13(26%) 
patients and in Group B, 5(10%) patients had normal 
BMI within 18.5-24.9 kg/m2. Comparison of both 
groups was significant with P=0.013 value.
In Group A, 30(60%) patients had healthy 
dietary habits and 20(40%) patients had unhealthy 
dietary habits. In Group B, 37(74%) patients had 
unhealthy dietary habits (atisnigdha, guru, atimadhur 
and mixed diet) and 13(26%) patients had healthy 
dietary habits. Comparison of both groups was 
significant with P=0.0006 value.
In Group A, 33(66%) patients had regular nidra 
(sleep) and 17(34%) patients had irregular nidra (sleep) 
whereas in Group B, 34 (68%) patients had regular and 
16 (32%) patients had irregular nidra (sleep). 
Comparison of both groups was not significant. 
In Group A, stress was present in 21(42%) 
patients whereas in Group B stress was present in 35 
(70%). Comparison of both groups was significant with 
P=0.0001 value  
In Group A, 31(62%) patients had no any type 
of vyasan (habit/addiction). In Group B 22(44%) 
patients have no any type of vyasan (habit/addiction). 
whereas remaining 28 (56%) patients had varying type 
of vyasan (habit/addiction) like alcohol, tobacco, 
smoking and tea. Comparison of both groups was 
significant with P=0.044 value.
In Group A, 25(50%) patients and in Group B 
29(58%) patients were not doing any type of physical 
exercise. Remaining patients were doing exercise like 
walking and yoga. Comparison of both groups was not 
significant. 
Systolic and diastolic blood pressure in both 
groups was normal and comparison of both groups was 
not significant.
In Group A, 9 (18%) patients had Diabetes 
mellitus and 41(82%) patients had no Diabetes mellitus. 
In Group B, 23(46%) patients had Diabetes mellitus 
whereas 27(54%) patients had no Diabetes mellitus. 
Comparison of both groups was significant with 
P=0.0027 value.
In Group A, 12(24%), 25(50%) and 13(26%) 
patients had sthul (obese), madhyam (medium) and 
krusha (emaciated) akruti (physique) respectively 
whereas in Group B, 25(50%), 22(44%) and 3(6%) 
patients had sthul, madhyam and krush  aakruti 
respectively. Comparison of both groups was significant 
with P=0.004 value.
94

Sadhana Misar Wajpeyi et.al., Analysis of Etiological Factors of Dyslipidemia -A Case Control Study
Published online in http://ijam.co.in ISSN No: 0976-5921
In Group A, average Blood Sugar level was 
116.62±47.45 and in Group B, average Blood Sugar 
level was 140.84±51.24. Comparison was significant 
with t and p value (t=2.45, p= 0.016)
 In Group A, average total cholesterol level was 
163.84±20.86 and in Group B, average total cholesterol 
level was 218.36±30.44. Comparison was significant 
with t and p value (t=10.44, p=0.0001).
 In Group A, average triglyceride level was 
122.82±26.29 and in Group B, average triglyceride 
level was 170.08±66.44. Comparison was significant 
with t and p values (t=4.67, p= 0.0001).
In Group A, average LDL level was 
96.86±15.28 and in Group B, average LDL level was 
147.86±31.39.Comparison of both groups was 
significant with t and p values (t=10.32, p=0.0001).
In Group A, average HDL level was 34.14±4.19 
and in Group B, average HDL level was 34.88±6.42. 
Comparison of both groups was not significant with t 
and p values (t=0.68, p=0.47).
In Group A average VLDL level was 
27.02±6.98 and in Group B, average VLDL level was 
31.72±11.68.Comparison of both groups was not 
significant with t and p values (t=2.44, p= 0.016).
Discussion 
Dyslipidemia is a metabolic disorder related to 
abnormal fat metabolism. Dyslipidemia is one of the 
risk factors which cause atherosclerosis, stroke and 
cardiovascular diseases (CVDs). But it can be prevented 
by adopting healthy dietary habits and lifestyle. These 
two measures can also be adopted to correct the 
Dyslipidemia. 
Lipid abnormalities were calculated as total 
cholesterol (TC) >200, serum triglyceride >150, low 
density lipoprotein (LDL) >130 mg/dl, high density 
lipoprotein (HDL) <40. Cholesterol/ HDL ratio >4.5 
according to the criteria set by the National Cholesterol 
Education Program-Adult Treatment Panel III (NCEP 
ATP III).(11) Statistical analysis showed that, in Group 
B (Case group) majority of the patients (34%) belonged 
to the age group 51-60 years. In research conducted by 
Padhar Chhaganbhai et.al. found maximum patients 
(32%) were between 40-50 years age group, which 
matches with result of this study.(12) In research 
conducted by Jyoti BJ et.al. they observed Dyslipidemia 
in majority subjects belonged to 20 to 29 years (51.5%, 
n=17) followed by age group 30 to 39 and 50 to 59 
(18.2 %, n=6 in each of them) indicating the shift of 
predominance from older age group to younger age 
group, which is not similar to the findings in this study.
(13) In group B, female were more (58%) in number. 
Research conducted by Pooja and Bhatted observed 
male dominance 63.33% in their study, which did not 
match with this study. They found service class patients 
(38%) and the housewives (34%) more in number in 
their study. They observed a greater number of patients 
(70%) from middle socioeconomic class, these findings 
had similarity with results of this study (14).Mandagni 
and  Aam formation are two main pathological factors 
of Medoroga described in Ayurveda. But in this study 
Maximum patients (64%) had sama Agni. Family 
history of Dyslipidemia was present in maximum 
patients (58%) of group B (case group), which is major 
risk factor of Dyslipidemia. Medoroga is mainly found 
in kaphadushti. Maximum patients (28%) belonged to 
kaphajavataja prakruti in group B. Majority patients 
(40%) had Body Mass Index (BMI) in the range of 
25-29.9 kg/m2 and (50%) had BMI ≥30kg/m2 (normal 
range-18-24kg/m2) in group B. Manjiri Arun Nadkarni 
et.al. in their study found BMI greater than 25 kg/m2  in 
81.96% of patients, which shows similarity with results 
of this study (15). BMI more than 25 kg/m2  is 
considered as obese and BMI ≥30kg/m2 is considered as 
severely obese, which is the major risk factor for 
Dyslipidemia. Maximum patients (90%) had sthul 
prakruti (obesity) in group B. Most of the patients in 
group B had unhealthy dietary habits (74%) 
atimadhur(excessive sweet), guru (heavy to digest), 
snigdha (oily) and  mixed type of food. In research 
conducted by Shivam G Joshi et.al. found that majority 
of (91.33%) patients had diet rich in Madhura Rasa, 
Snigdha Guna (70%), Guru Guna (65%), and 
SheetaVeerya (63%). They observed more number of 
patients (68.33%) had Vishamashana and Adhyashana, 
which are the major risk factors of Dyslipidemia (16). 
Indulgence in Kaphavardhakaahara leads to 
Medovriddhi and causes “Medoroga”. Vyasan (Bad 
habits like alcohol consumption, smoking, tobacco and 
tea ) was present in maximum (56%) number of patients 
in group B. Consumption of alcohol, smoking and 
tobacco are the major risk factors for Dyslipidemia as it 
interfere with fat metabolism and leads to Dyslipidemia. 
Majority of patients (58%) were not adapted to any type 
of physical exercise in group B. Sedentary life is one of 
the major cause of obesity and Dyslipidemia. Stress was 
present in most of the patients (70%) of group B, which 
is also risk factor for Dyslipidemia. Average Systolic 
Blood pressure was 126.20±9.66 and diastolic Blood 
pressure was 80.60±7.39 in group B whereas Diabetes 
mellitus was present in majority of the patients (46%) of 
group B. Diabetes mellitus is one of the risk factor of 
Dyslipidemia. Similar types of findings were reported 
by other researchers in their studies conducted on 
Dyslipidemia.
Swapnil S. Auti, conducted research study on 
Dyslipidemia and their study findings consists of most 
of the above mentioned etiological factors in their study 
(17).
Advanced age, sedentary lifestyle, lack of 
exercise, stress, obesity, unhealthy dietary habits, family 
history of Dyslipidemia, alcohol consumption, smoking, 
tobacco chewing, hypertension and Diabetes mellitus 
are the major risk factors for Dyslipidemia.(18). 
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In this study statistical analysis showed that 
Dyslipidemia was significantly associated with 
unhealthy dietary habits , family history of 
Dyslipidemia, obesity, alcohol consumption, smoking, 
tobacco, tea and Diabetes mellitus. But the other factors 
like advanced age, sedentary lifestyle, lack of exercise, 
stress and hypertension are factors also related to cause 
Dyslipidemia. Hence from this study it can be 
concluded that it is not necessary that all the etiological 
factors are needed in the pathogenesis of Dyslipidemia 
but it can be cause due to presence of some of them. 
According to the factors found in this study it can be 
stated that  patients having family history  of 
Dyslipidemia, obesity, bad habits like alcohol 
consumption, smoking, tobacco and diabetes mellitus 
have high risk of Dyslipidemia and should be screened 
for early diagnosis. The lack of awareness about 
benefits of healthy diet and regular physical activity 
may increase the risk of Dyslipidemia which is one of 
the major risk factor for cardiovascular and 
cerebrovascular disorders. Hence, emphasis should be 
given on regular awareness programs on lifestyle 
modification and its benefits for reducing the risk of 
cardiovascular diseases. Screening programs for early 
detection of Dyslipidemia in populations having 
association with above mentioned etiology should be 
conducted so that it can be treated in early stage with 
lipid lowering drugs and life style modifications to 
reduce the risk of atherosclerosis.
Conclusion 
The prevalence of metabolic disorders like 
Dyslipidemia is increasing day by day due to unhealthy, 
faulty dietary habits, sedentary lifestyle, stress, 
hypertension and Diabetes mellitus. From this study it 
can be concluded that advanced age, sedentary lifestyle, 
unhealthy dietary habits like consumption of excessive 
sweet, oily food, stress, obesity, hypertension, Diabetes 
mellitus are risk factors of Dyslipidemia. The findings 
of this study showed that all risk factors are not 
contributing in pathogenesis of disease but they differ in 
each individual. Factors like unhealthy dietary habits, 
bad habits like alcohol consumption, smoking, tobacco, 
obesity, Diabetes mellitus are major factors associated 
with Dyslipidemia. People should be made aware about 
these risk factors to avoid such type of causes and 
prevent these disorders. Screening of people having 
above risk factors also helps in early diagnosis and 
treatment of the disease.
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